Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Single-center, Single-arm and Phase II/III Clinical Study of Paclitaxel (Albumin-binding) Combined With Oxaliplatin as First-line Treatment for Advanced Hepatobiliary and Malignant Tumors

NCT04060472 is registered in ClinicalTrials.gov with Dong Wang as lead sponsor.

NCT NCT04060472
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04060472 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Single-center, Single-arm and Phase II/III Clinical Study of Paclitaxel (Albumin-binding) Combined With Oxaliplatin as First-line Treatment for Advanced Hepatobiliary and Malignant Tumors
Lead sponsor
Dong Wang
Phase
Phase 2/3
Overall status
Unknown status
Start date
August 20, 2019
Completion date
October 20, 2023
Enrollment
57 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

advanced hepatobiliary and malignant tumors